Pharma manufacturing research institute announces 32 projects

313
Advertisement

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan.

Newark-based NIIMBL identified projects that will help the nation prevent, prepare for, and respond to coronavirus health threats, a release stated Six of the projects establish research and development testbeds that will support collaborative research by the NIIMBL community at its Newark headquarters.

The decision to locate the center to the University of Delaware STAR Campus marked a milestone in efforts to bolster the state’s life sciences industry.

“To move past the current pandemic and prepare for future public health threats, we must continue to create the technology, infrastructure, and skills that are needed,” said Kelvin Lee, institute director. “This diverse group of technology and workforce development projects addresses multiple public health response capabilities and strengthens the United States’ role as a global leader in biopharmaceutical manufacturing.

Approved projects with regional players include:

Advertisement
  • Supporting Pharmaceutical and Bioproduction Manufacturing with a Certificate in Laboratory Techniques to Provide an Entry-Level Workforce. Lead Organization: Cecil College
  • Establishing Testbeds for Biopharmaceutical Manufacturing Workforce Development. Lead Organizations: Texas A&M University, University of Delaware, North Carolina Central University, Xavier University of Louisiana, University of Maryland Baltimore County
  • Affinity Precipitation Purification of Virus-Like Particles. Lead Organization: University of Delaware
  • Development of Scalable, Thermostable, Spray Dried Vaccine Formulations Applicable for Coronavirus Vaccines. Lead Organizations: Fraunhofer USA, Merck & Co.
  • Enhancement of the End-to-End Manufacturing Testbed for Fast, Flexible Drug Substance Manufacturing. Lead Organization: NIIMBL
  • Next Generation Sequencing Testbed..Lead Organization: NIIMBL
  • Portable GMP Plasmid Production Testbed. Lead Organization: NIIMBL
  • NIIMBL Vaccine Analytics and Assays Center of Excellence. Lead Organization: NIIMBL
  • Process Development TestbedLead Organization: NIIMBLGMP-like Drug Product Testbed LaboratoryLead Organization: NIIMBL

More information on other projects is available at NIIMBL.org.

Advertisement
Advertisement